No conflict of interest was declared.
Original Report
Identification of responders and reactive domains to rivastigmine in Alzheimer's disease†
Article first published online: 16 NOV 2006
DOI: 10.1002/pds.1345
Copyright © 2006 John Wiley & Sons, Ltd.
Additional Information
How to Cite
Frankfort, S. V., Appels, B. A., de Boer, A., Tulner, L. R., van Campen, J. P. C. M., Koks, C. H. W., Beijnen, J. H. and Schmand, B. A. (2007), Identification of responders and reactive domains to rivastigmine in Alzheimer's disease. Pharmacoepidem. Drug Safe., 16: 545–551. doi: 10.1002/pds.1345
- †
Publication History
- Issue published online: 1 MAY 2007
- Article first published online: 16 NOV 2006
- Manuscript Accepted: 3 OCT 2006
- Manuscript Revised: 20 SEP 2006
- Manuscript Received: 23 MAY 2006
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.
Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!

1099-1557/asset/PDS_left.gif?v=1&s=f962ae698249deba4dc56217f1bb95eac528fe4d)
1099-1557/asset/PDS_right.gif?v=1&s=44103455c6e4e28135198609bb6a426efee9a51c)
1099-1557/asset/cover.gif?v=1&s=3d84b3516e1c56285d541e803f7d990de33f9824)